Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

BMJ. 2002 Jun 1;324(7349):1287-8. doi: 10.1136/bmj.324.7349.1287.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis / drug therapy*
  • Arthritis, Rheumatoid / drug therapy
  • Celecoxib
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Humans
  • Ibuprofen / adverse effects
  • Ibuprofen / therapeutic use
  • Isoenzymes / adverse effects
  • Isoenzymes / antagonists & inhibitors*
  • Membrane Proteins
  • Osteoarthritis / drug therapy
  • Prostaglandin-Endoperoxide Synthases / adverse effects
  • Pyrazoles
  • Research Design
  • Stomach Ulcer / chemically induced*
  • Sulfonamides / adverse effects
  • Sulfonamides / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Pyrazoles
  • Sulfonamides
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Celecoxib
  • Ibuprofen